Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EEF1A1P45 is a processed human pseudogene on chromosome X derived from the parent gene EEF1A1, which encodes the eukaryotic translation elongation factor 1 alpha 1. EEF1A1 is a GTPase that delivers aminoacyl-tRNAs to the ribosome during protein synthesis[2][4]. The EEF1A1 gene has many pseudogenes across the human genome, of which EEF1A1P45 is one, but these are typically classified as processed pseudogenes (resulting from retrotransposition). There is no evidence that EEF1A1P45 is expressed, nor is it known to be involved in cellular processes or disease[1][3]. It should not be considered a biological target, receptor, drug target, or biomarker under standard conventions. If you require structured information on the parent gene EEF1A1 (the functional protein-coding gene), that entry would have numerous roles in cell biology and disease — but EEF1A1P45 itself, as a pseudogene, has no direct functional or therapeutic relevance[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 45 (EEF1A1P45).